Chemoinformaics analysis of 2-[(1R)-2,2,3-TRIMETHYLCYCLOPENT-3-EN-1-YL]ACETALDEHYDE
| Molecular Weight | 152.237 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 6 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -2.989 | nHRing | 0 |
| Solubility: LogP | 2.72 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.439 |
| Synth | 3.651 |
| Natural Product Likeliness | 2.276 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.363 |
| MDCK | 0.0000203 |
| BBB | 0.975 |
| PPB | 0.524764 |
| VDSS | 2.311 |
| FU | 0.442541 |
| CYP1A2-inh | 0.081 |
| CYP1A2-sub | 0.443 |
| CYP2c19-inh | 0.056 |
| CYP2c19-sub | 0.8 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.783 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.653 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.268 |
| CL | 9.867 |
| T12 | 0.246 |
| hERG | 0.004 |
| Ames | 0.01 |
| ROA | 0.022 |
| SkinSen | 0.951 |
| Carcinogencity | 0.686 |
| EI | 0.987 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.926663 |